Effect of Maraviroc on Metabolic Function in Obese Subjects (Phase I)
Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effect of maraviroc therapy in obese insulin
resistant subjects on:
1. Plasma triglyceride concentration
2. Plasma HDL-cholesterol and LDL-cholesterol concentrations
3. Plasma markers of cardiometabolic risk and inflammation